Journal
CIRCULATION
Volume 116, Issue 11, Pages I31-I37Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.106.680157
Keywords
diabetes; angiogenesis; endothelium; ischemia; growth factors
Funding
- NHLBI NIH HHS [K30 HL004095, R01 HL085647, R01 HL069024, HL04095-06, R01 HL085647-01A2, R01 HL69024] Funding Source: Medline
Ask authors/readers for more resources
Background - Ischemic heart disease is the most common cause of mortality in diabetic patients. Although therapeutic angiogenesis is an attractive option for these patients, they appear to have reduced collateral formation in response to myocardial ischemia. The aims of this study were to establish a large animal model of diabetes and chronic myocardial ischemia, evaluate the effects of diabetes on the angiogenic response, and elucidate the molecular pathways involved. Methods and Results - Diabetes was induced in male Yucatan miniswine using a pancreatic beta-cell specific toxin, alloxan (150 mg/kg; n = 8). Age-matched swine served as controls (n = 8). Eight weeks after induction, chronic ischemia was induced by ameroid constrictor placement around the circumflex coronary artery. Myocardial perfusion and function were assessed at 3 and 7 weeks after ameroid placement using isotope-labeled microspheres. Endothelial cell density and myocardial expression of angiogenic mediators was evaluated. Diabetic animals exhibited significant endothelial dysfunction. Collateral dependent perfusion and LV function were significantly impaired in diabetic animals. Diabetic animals also demonstrated reduced endothelial cell density (173 +/- 14 versus 234 +/- 23 cells/hpf, P = 0.03). Expression of VEGF, Ang-1, and Tie-2 was reduced, whereas antiangiogenic proteins, angiostatin (4.4 +/- 0.9-fold increase, P < 0.001), and endostatin (2.9 +/- 0.4-fold increase, P = 0.03) were significantly elevated in the diabetic myocardium. Conclusions - Diabetes results in a profound impairment in the myocardial angiogenic response to chronic ischemia. Pro- and antiangiogenic mediators identified in this study offer novel targets for the modulation of the angiogenic response in diabetes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available